PT  - JOURNAL ARTICLE
AU  - Gibson, Michael K
AU  - Savvides, Panayiotis
AU  - Worden, Francis
AU  - Heimann-Nichols, Ellen
AU  - Wu, TC
AU  - Roden, Richard
AU  - Chang, Yung-Nien
TI  - 677 Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal cancer
AID  - 10.1136/jitc-2023-SITC2023.0677
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A768--A768
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A768.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A768.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.